Edison Investment Research - Asit Biotech SA (ASIT) ASIT biotech - Executive Interview

Report

Edison Investment Research

Andy Smith

ASIT biotech - Executive Interview

In this Michel Baijot, CEO of , discusses what is unique about the company and what newsflow investors can expect from ASIT in the second half of 2019.

23/07/2019 1 EN

Underlying

Asit Biotech SA

Asit Biotech SA. Asit Biotech SA, formerly Biotech Tools SA, is a Belgium- based company that develops products aimed to prevent negative response of the immune system.

See profile

BE0974289218 Euronext Brussels Belgium

Provider

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

See profile

Analysts

Andy Smith

Other Reports on these Companies

BusinessWire

DMS Imaging : Déclaration de transparence reçue de la part de Mr R. de Spoelberch

BRUXELLES--(BUSINESS WIRE)-- Regulatory News: Anciennement ASIT Biotech DMS Imaging (anciennement ASIT Biotech) (DMSIM - BE0974289218) (BSE:DMSIM) (Paris:DMSIM), annonce aujourd’hui avoir reçu une notification de la position actionnariale de Mr R. de Spoelberch, datée du 8 mars 2022, conformément à la loi belge du 2 mai 2007 relative à la publication des participations importantes détenues dans des sociétés dont les actions sont admises à la négociation sur un marché réglementé belge. La déclaration datée du 8 mars 2022 comprend les informations suivantes : Motif de la notification : Fran...

March 17, 2022 March 17, 2022 1 FR

BusinessWire

DMS Imaging : Information sur le nombre total de droits de vote et d’actions

BRUXELLES--(BUSINESS WIRE)-- Regulatory News: DMS Imaging (anciennement ASIT Biotech) (DMSIM - BE0974289218) (BSE:DMSIM) (Paris:DMSIM) publie aujourd’hui l’information conformément à l’article 15 de la loi belge du 2 mai 2007 relative à la publication des participations importantes. Informations au 28 février 2022 : Montant total du capital social : 66 071 856,50 € Nombre total de titres conférant le Droit de Vote Unique : 1 489 607 331 Nombre total des actions ordinaires en circulation : 1 489 607 331 Nombre total de Droits de Vote : 1 489 607 331 *** A propos de DMS Imaging Spé...

February 28, 2022 February 28, 2022 1 FR

BusinessWire

DMS Imaging: Publication relative à une notification de transparence

BRUXELLES--(BUSINESS WIRE)-- Regulatory News: DMS Imaging (anciennement ASIT Biotech) (DMSIM - BE0974289218) (BSE:DMSIM) (Paris:DMSIM), annonce aujourd’hui avoir reçu une notification de transparence datée du 25 février 2022, dont il résulte que, suite à une augmentation de capital réalisée en date du 24 janvier 2022 dans le cadre de l’apport en nature de la division imagerie médicale de Diagnostic Medical Systems à la Société, Diagnostic Medical Systems détient donc désormais 88,33% des droits de vote de la Société et franchit le seuil de 85%. La déclaration datée du 25 février 2022 compren...

February 28, 2022 February 28, 2022 1 FR

Manx Financial Group - Termination of coverage

Edison Investment Research is terminating coverage on Manx Financial Group (MFX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant. Previously published reports can still be accessed via our website.

March 10, 2025 March 10, 2025 1 EN

Kate Heseltine

Kate Heseltine

musicMagpie - Termination of coverage

Edison Investment Research is terminating coverage on musicMagpie (MMAG). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant. Previously published reports can still be accessed via our website.

March 5, 2025 March 5, 2025 1 EN

Kate Heseltine

Kate Heseltine

Topps Tiles - Accelerating growth through Q125

Topps Tiles (TPT) is enjoying a return to revenue growth following a very challenging FY24 due to wider macroeconomic weakness. The company’s recovery is clearly being boosted by new revenue streams from its self-help initiatives, notably from trade and online customers across all of its brands. While the macroeconomic environment remains uncertain, it is pleasing that the strategy is supporting growth. The valuation continues to look compelling, even with limited macroeconomic recovery included in management’s long-term financial goals. With the Q125 trading update, the CEO has announced his ...

January 10, 2025 January 10, 2025 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

ASIT biotech - Executive Interview

DMS Imaging : Déclaration de transparence reçue de la part de Mr R. de Spoelberch

DMS Imaging : Information sur le nombre total de droits de vote et d’actions

DMS Imaging: Publication relative à une notification de transparence

Manx Financial Group - Termination of coverage

musicMagpie - Termination of coverage

Topps Tiles - Accelerating growth through Q125

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe